Skip to main content
Signal8
SZOSTAK M ANNE profile photo

M. Anne Szostak

CIK: 0001094176

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (33.3%)

Position reduction

Option Exercises (M)4 (26.7%)

Derivative conversions

Awards (A)2 (13.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (26.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IDEXX LABORATORIES INC /DE logo
IDXX

IDEXX LABORATORIES INC /DE

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    May 7, 2026
    Exercise(M)
    Direct
    257 shares-
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Aug 22, 2025
    Sale(S)
    Direct
    2.2K shares at avg. $647.33$1.4M
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Aug 22, 2025
    Gift(G)
    Indirect
    259 shares-
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Aug 22, 2025
    Exercise(M)
    Direct
    2.2K shares at avg. $206.62$452K
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Aug 22, 2025
    Gift(G)
    Indirect
    259 shares-
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    May 21, 2025
    Sale(S)
    Indirect
    1.3K shares at avg. $512.34$646K
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    May 21, 2025
    Exercise(M)
    Direct
    1K shares at avg. $160.28$168K
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    May 21, 2025
    Sale(S)
    Direct
    1K shares at avg. $513.74$537K
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    May 7, 2025
    Award(A)

    Non-Qualified Stock Option (right-to-buy)

    Direct
    600 shares-
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    May 7, 2025
    Award(A)

    Restricted Stock Unit

    Direct
    257 shares-
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    May 6, 2025
    Exercise(M)
    Direct
    262 shares-
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Feb 7, 2025
    Sale(S)
    Indirect
    3K shares at avg. $465.94$1.4M
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Sep 6, 2024
    Sale(S)
    Indirect
    500 shares at avg. $469.37$235K
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Sep 5, 2024
    Gift(G)
    Indirect
    500 shares-
  • IDEXX LABORATORIES INC /DE logo
    IDXX

    IDEXX LABORATORIES INC /DE

    Sep 5, 2024
    Gift(G)
    Indirect
    500 shares-

1-15 of 15

About SZOSTAK M ANNE

SZOSTAK M ANNE (SEC CIK 0001094176) files insider reports with the SEC as Director of IDEXX LABORATORIES INC /DE (IDXX).

Signal8 holds 6 ownership filings by SZOSTAK M ANNE, all Form 4s, filed between Sep 9, 2024 and May 11, 2026. Those filings report 15 transactions, from Sep 5, 2024 to May 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SZOSTAK M ANNE's filings is in WESTBROOK, ME.

Recent filings by SZOSTAK M ANNE

  • May 7, 2026: Option exercise of IDXX shares (Form 4, code M).
  • Aug 22, 2025: Open-market sale of IDXX shares (Form 4, code S).
  • Aug 22, 2025: Gift of IDXX shares (Form 4, code G).
  • Aug 22, 2025: Option exercise of IDXX shares (Form 4, code M).
  • Aug 22, 2025: Gift of IDXX shares (Form 4, code G).

Other insiders filing for IDEXX LABORATORIES INC /DE (IDXX)

How to read Form 4 transaction codes